MHC antigens and tumor escape from immune surveillance
- PMID: 11665717
- DOI: 10.1016/s0065-230x(01)83005-0
MHC antigens and tumor escape from immune surveillance
Similar articles
-
Ex vivo-activated MHC-unrestricted immune effectors for cancer adoptive immunotherapy.Anticancer Agents Med Chem. 2014 Feb;14(2):211-22. doi: 10.2174/18715206113136660371. Anticancer Agents Med Chem. 2014. PMID: 24237224 Review.
-
HLA class I antigens in human tumors.Adv Cancer Res. 1995;67:155-95. doi: 10.1016/s0065-230x(08)60713-7. Adv Cancer Res. 1995. PMID: 8571814 Review. No abstract available.
-
Tumour MHC class I downregulation and immunotherapy (Review).Oncol Rep. 2003 Nov-Dec;10(6):2005-8. Oncol Rep. 2003. PMID: 14534734 Review.
-
MHC class I and II gene expression on human tumors.Adv Exp Med Biol. 1988;233:119-28. doi: 10.1007/978-1-4899-5037-6_14. Adv Exp Med Biol. 1988. PMID: 3146901 Review. No abstract available.
-
MHC class I antigens, immune surveillance, and tumor immune escape.J Cell Physiol. 2003 Jun;195(3):346-55. doi: 10.1002/jcp.10290. J Cell Physiol. 2003. PMID: 12704644 Review.
Cited by
-
Unveiling the Immunogenicity of Ovarian Tumors as the Crucial Catalyst for Therapeutic Success.Cancers (Basel). 2023 Dec 2;15(23):5694. doi: 10.3390/cancers15235694. Cancers (Basel). 2023. PMID: 38067396 Free PMC article. Review.
-
Quantification of HLA class I molecules on renal cell carcinoma using Edman degradation.BMC Urol. 2011 Jan 20;11:1. doi: 10.1186/1471-2490-11-1. BMC Urol. 2011. PMID: 21251276 Free PMC article.
-
Recognition of tumors by the innate immune system and natural killer cells.Adv Immunol. 2014;122:91-128. doi: 10.1016/B978-0-12-800267-4.00003-1. Adv Immunol. 2014. PMID: 24507156 Free PMC article. Review.
-
Dysfunction of antigen processing and presentation by dendritic cells in cancer.Mol Immunol. 2019 Sep;113:31-37. doi: 10.1016/j.molimm.2018.03.025. Epub 2018 Apr 5. Mol Immunol. 2019. PMID: 29628265 Free PMC article. Review.
-
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers.Front Immunol. 2024 Feb 22;15:1285049. doi: 10.3389/fimmu.2024.1285049. eCollection 2024. Front Immunol. 2024. PMID: 38455061 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials